https://endpts.com/pd-l1-pioneer-lieping-chen-rachel-humphrey-spin-out-new-biotech-to-break-down-the-door-on-cold-tumors/
Understanding that patient recruitment has been slow for clinical trials since the pandemic, it would still be nice to know if NOX have clinical proof of concept for the cold to hot tumor conversion hypothesis. This space is heating up and it pays to be first.
Ann: Veyonda and Opdivo IONIC Study First Patient Dosed, page-37
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.04M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 72463 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 8810 | 1 |
View Market Depth
| Last trade - 10.16am 29/07/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable